A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM) Meeting Abstract

   

Authors:	Clarke, J.; Sul, J.; DeAngelis, L.; Lassman, A.; Hormigo, A.; Nolan, C.; Gavrilovic, I.; Gu, B.; Panageas, K.; Abrey, L.
Abstract Title:	A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
Meeting Title:	12th Annual Meeting of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	9
Issue:	4
Meeting Dates:	2007 Nov 15-18
Meeting Location:	Dallas, TX
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2007-10-01
Start Page:	530
Language:	English
ACCESSION:	WOS:000249999100246
PROVIDER:	wos
DOI:	10.1215/15228517-2007-039
PMCID:	PMC1994106
Notes:	Meeting Abstract: MA-57 -- "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/25427